Edition:
United States

Accuray Inc (ARAY.OQ)

ARAY.OQ on NASDAQ Stock Exchange Global Select Market

4.25USD
23 Oct 2017
Change (% chg)

-- (--)
Prev Close
$4.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
118,750
52-wk High
$6.00
52-wk Low
$3.60

Chart for

About

Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife... (more)

Overall

Beta: 1.24
Market Cap(Mil.): $355.96
Shares Outstanding(Mil.): 83.75
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 163.65 16.52
EPS (TTM): -- -- --
ROI: -- 9.60 11.32
ROE: -- 14.98 15.18

BRIEF-European Court Of Appeal rejects Varian's attempt to reverse customer purchase of Accuray TomoTherapy system

* European Court Of Appeal rejects Varian's attempt to reverse customer purchase of Accuray TomoTherapy system

Oct 19 2017

BRIEF-Accuray reports Q4 loss per share of $0.06

* Accuray reports fourth quarter and fiscal 2017 financial results

Aug 22 2017

BRIEF-Accuray issues $85 mln principal amount of 3.75 pct convertible senior notes

* Accuray Inc says ‍on August 7, issued $85 million aggregate principal amount of its 3.75% convertible senior notes due 2022 - sec filing​ Source text: (http://bit.ly/2umHI40) Further company coverage:

Aug 08 2017

BRIEF-Accuray says receives 510(k) clearance for IDMS data management system upgrade for Tomotherapy system

* Says receives 510(k) clearance for IDMS data management system upgrade for Tomotherapy system Source text for Eikon: Further company coverage:

Jul 31 2017

BRIEF-Accuray enhances capital structure through convertible debt transactions

* Accuray Inc - company has also entered into agreements to privately sell $32 million aggregate principal amount of new notes for cash to certain other investors

Jul 28 2017

BRIEF-Neuro Spinal Hospital in Dubai to buy Accuray Cyberknife and Radixact Systems

* Accuray Inc - ‍deal was entered into backlog during Accuray's fourth fiscal quarter which ended June 30, 2017​

Jul 11 2017

BRIEF-Accuray Inc signs new revolving loan agreement

* Closed a new $52 million senior secured revolving loan facility with Midcap Financial Trust Source text for Eikon: Further company coverage:

Jun 15 2017

BRIEF-Accuray reports prelim data from phase I trial of breast cancer cure treated with Cyberknife System

* Prelim data from phase I trial evaluating adjuvant stereotactic partial breast irradiation in early stage breast cancer patients treated with Cyberknife System

May 02 2017

BRIEF-Accuray Q3 loss per share $0.06

* Accuray Inc - gross product orders totaled $83.8 million for 2017 fiscal Q3 compared to $56.4 million for prior fiscal year period

Apr 27 2017

Competitors

Earnings vs. Estimates